Central European Journal of Medicine

, Volume 3, Issue 2, pp 195–198 | Cite as

The prevalence of Parkinson’s disease among Vilnius inhabitants

  • Vaineta Valeikiene
  • Jelena Ceremnych
  • Diana Mieliauskaite
  • Vidmantas Alekna
Research Article


In a hospital-based study we investigated the prevalence of Parkinson’s disease among inhabitants of the Vilnius city, the capital of Lithuania. The study group was selected from patients who were diagnosed with Parkinson’s disease during the time frame of 1978-2005. Patients’ time of diagnosis were based on the data of dispensary cards, registration journals and/or other documentation. A questionnaire and Mini Mental State Examination provided data for analysis on the conditions of the patients. The prevalence of Parkinson’s disease in Vilnius is 1.32/1000 inhabitants and is higher in men than in women (p < 0.05). The age of Parkinson’s disease onset in men and women is the same (63.77 ± 0.70 years). The rigidity-tremor form of Parkinson’s disease is the most frequent (76.8% of all cases). The PD prevalence rate in Vilnius inhabitants are close to the mean levels observed in studies made in Finland, Austria, Germany. The prevailing form of Parkinson’s disease is rigidity-tremor.


Parkinson’s disease Prevalence Epidemiological study 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Lang A.E., Lozano A.M., Medical progress: Parkinson’s disease. Part 1., N. Engl. J. Med., 1998, 339, 1044–1053PubMedCrossRefGoogle Scholar
  2. [2]
    Nakashima K., Maeda M., Tabata M., Achachi Y., Kusumi M., Ohshiro H., Prognosis of Parkinson’s disease in Japan., Versicherungsmedizin., 1997, 49(4), 126–131Google Scholar
  3. [3]
    Werner M., Fornadi F., Effect of early diagnosis and therapy on prognosis of Parkinson syndrome., Versicherungsmedizin., 1997, 49(4), 126–131PubMedGoogle Scholar
  4. [4]
    Ben-Sholomo Y., Descriptive epidemiology of Parkinson’s disease through proxy measures., Can. J. Neurol. Sci., 1996, 6(1), 279–284Google Scholar
  5. [5]
    Pepper P.V., Goldstein M.K., Postoperative complications in Parkinson’s disease., J. Am. Geriatr. Soc., 1999, 47(8), 967–972PubMedGoogle Scholar
  6. [6]
    McCann S.J., LeCouteur D.G., Green A.C., Brayne C., Johnson A.G., Chan D., et al., The epidemiology of Parkinson’s disease in an Australian population., Neuroepidemiology., 1998, 17(6), 310–317PubMedCrossRefGoogle Scholar
  7. [7]
    Mayeux R., Marder K., Cote L., Denaro J., Hemenegildo N., Mejia H., et al., The frequency of idiopatic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988-1993, Am. J. Epidemiol., 1995, 142(8), 820–827PubMedGoogle Scholar
  8. [8]
    De Leest B.J., Goluke-Willemse G.A., Parkinsonizm. The differential diagnosis., Tijdschr. Gerontol. Geriatr., 1998, 9(5), 250–257Google Scholar
  9. [9]
    Tanner C.M., Goldman S.M., Epidemiology of Parkinson’s disease., Neurol. Clin., 1996, 14(2), 317–336PubMedCrossRefGoogle Scholar
  10. [10]
    Kuopio A.M., Marttila R.J., Helenius H., Rinne U.K., Changing epidemiology of Parkinson’s disease in southwestern Finland., Neurology., 1999, 52(2), 302–308PubMedGoogle Scholar
  11. [11]
    Kusumi M., Nakashima K., Harada H., Nakayama H., Takahashi K., Epidemiology of Parkinson’s disease in Yonago City, Japan: comparison with a study caried out 12 years ago., Neuroepidemiology., 1996, 15(4), 201–207PubMedCrossRefGoogle Scholar
  12. [12]
    Zhang Z.H., Roman G.C., Worldwide occurrence of Parkinson’s disease: an updated review., Neuroepidemiology., 1993, 12, 195–208PubMedCrossRefGoogle Scholar
  13. [13]
    Zhang Z.H., Hong X., Huang J.B., Wang J.M., Wei J., et al., Is China a low risk area for Parkinson’s disease?, Mov. Disord., 1998, 13(Suppl 2), 79Google Scholar
  14. [14]
    Calne D.B., Snow B.J., Lee C., Criteria for diagnosing Parkinson’s disease., Ann. Neurol., 1992, 32 (Suppl 1), S125–S127PubMedCrossRefGoogle Scholar
  15. [15]
    Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J., What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology., 1992, 42, 1142–1146PubMedGoogle Scholar
  16. [16]
    Hughes A.J., Daniel S.E., Kilford L., Lees A.J., Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases., J. Neurol. Neurosurg. Psychiatry., 1992, 55, 181–184PubMedCrossRefGoogle Scholar
  17. [17]
    Cheryl H. Waters. Diagnosis and management of Parkinson’s disease. California, 1998Google Scholar
  18. [18]
    Koller W.C., Montgomery E.B., Issues in the early diagnosis of Parkinson’s disease., Neurology., 1997, 49 (Suppl 1), S10–S25PubMedGoogle Scholar
  19. [19]
    Negoro K, Morimatsu M., Clinical and MRI correlation in multiple system atrophy., No To Shinkei, 1994, 46, 473–478PubMedGoogle Scholar
  20. [20]
    Valeikiene V., Juozulynas A., The incidence of Parkinson’s disease among Vilnius inhabitants. Gerontologija., 2006, 7(3), 131–136Google Scholar
  21. [21]
    Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., et al., Prevalence of parkinsonian signs and associated mortality in a community population of older people., N. Engl. J. Med., 1996, 334(2), 71–76PubMedCrossRefGoogle Scholar
  22. [22]
    Ben-Shlomo Y., The epidemiology of Parkinson’s disease., Baillieres Clin. Neurol., 1997, 6(1), 55–68PubMedGoogle Scholar
  23. [23]
    Maldonado R.G., The strange case of Dr Parkinson (A new look at ancient disease): English edition: Jean Lourse Sanders and Enrique Sauchez Vilchez., 1998Google Scholar
  24. [24]
    Hofman A., Ott A., de Rijk M.C., Breteler M.M.B., Prevalence of Alzheimer’s disease, vascular dementia, Parkinson’s disease and epilepsy in a Dutch population study: The Rotterdam Study., Neuroepidemiology., 1995, 14, 312Google Scholar
  25. [25]
    De Rijk M.C., Tzourio C., Breteler M.M., Dartigues J.F., Amaducci L., Lopez-Pousa S., et al., Prevalence of parkisonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease., J. Neurol. Neurosurg Psychiatry., 1997, 62(1), 10–15PubMedGoogle Scholar
  26. [26]
    Mutch W.J., Dingwall-Fordyce I., Downie A.W., Downie A.W., Paterson J.G., Roy S.K., Parkinson’s disease in a Scottish city., Br. Med. J., 1986, 292, 534–536Google Scholar
  27. [27]
    Martinez-Martin P., O’Brien C.F., Extending levodopa action. COMT inhibition., Neurology., 1998, 50(Suppl 6), S27–S32PubMedGoogle Scholar
  28. [28]
    Sveinbjornsdottir S., Gudmudsson G., Einarsson G., Epidemiology of Parkinson’s Disease (PD) in Iceland: the first 234 cases in a total population survey., Mov Disord., 1998, 13(Suppl 2), 142Google Scholar
  29. [29]
    Maskowitz C.B., Kopiryzi M., Petrela M., Fahn S. Parkinson’s disease in Albania (1995-1996)., Mov Disord., 1998, 13(Suppl 2), 298Google Scholar
  30. [30]
    Martinez-Martin P., Lens C., Franch O., et al., Costs of Parkinson’s disease in Spain. A pilot study in outpatients., Mov Disord., 1998, 13(Suppl 2), 62Google Scholar
  31. [31]
    Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., et al., Prevalence of parkinsonian signs and associated mortality in a community population of older people., N. Engl. J. Med., 1996, 334(2), 71–76PubMedCrossRefGoogle Scholar
  32. [32]
    Valeikiene V., Juozulynas A., Clinical data of Parkinson’s disease. Gerontologija., 2003, 4(2), 91–105Google Scholar
  33. [33]
    Valeikiene V., Derkintyte M., Quality of life in Parkinson’s disease. Gerontologija., 2003, 4(1), 13–17Google Scholar
  34. [34]
    Benito-Leon J., Bermejo-Pareja F., Rodriguez J., Molina J.A., Gabriel R., Morales J.M., The Neurological disorders in central Spain (NEDICES) study group. Prevalence of PD and other Parkinsonism in three elderly populations of central Spain. Mov Disord., 2003 Mar, 18(3), 267–274PubMedCrossRefGoogle Scholar
  35. [35]
    Benito-Leon J., Bermejo-Pareja F., Morales-Gonzales J.M., Porta-Etessem J., Trincado R., Vega S., et al., The Neurological disorders in central Spain (NEDICES) study group. Incidence of PD and other Parkinsonism in three elderly populations of central Spain. Neurology., 2004 Mar, 9, 62(3), 734–741PubMedGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Vaineta Valeikiene
    • 1
  • Jelena Ceremnych
    • 1
  • Diana Mieliauskaite
    • 1
  • Vidmantas Alekna
    • 1
  1. 1.Institute of Experimental and Clinical Medicine at Vilnius UniversityCenter of Gerontology and RehabilitationVilnius, LTLithuania

Personalised recommendations